Menu
Menu
The International Symposium on VIP, PACAP and Related Peptides (VPAC) was first held in 1993 in Strasbourg, France, and then held biennially worldwide. The International Society for Bioactive Peptides (ISBAP) was formerly known as the International Regulatory Peptide Society and was renamed its current name recently. Our great honor is to hold the 1st ISBAP meeting and the 15th VPAC symposium jointly this year in Osaka, Japan. The international symposium VPAC ISBAP 2022 aims to provide invaluable opportunities for the international exchange of researchers interested in VIP, PACAP, and many other related and bioactive peptides.
The symposium was once planned to be held in the spring of 2021 but was postponed several times due to the COVID-19 pandemic. Although it is highly unpredictable, the international steering committees of both societies have decided to hold this joint meeting this time. We understand that it is essential to ensure the chance to meet and discuss together, particularly for those who will lead the future research. Containing a wish for this, the organizing committee has subtitled the symposium “Toward Next Generation Peptide Research.” We welcome your attendance at the commemorable VPAC ISBAP 2022.
The congress will last 3 full days, from the 22nd to the 24th of September 2021, and will be entirely online. The scientific program elaborated by both the SNE’s and BSN’s scientific committees includes 4 plenary lectures and 4 symposia. The objective of the meeting is to highlight recent advances in Neuroendocrinology with the best specialists in the field.
7-10 August, 2022
SEC Glasgow, Scotland
15-18 July, 2018
The Westin Harbour CastleToronto, ON, Canada
August 17-20, 2014
Hilton Hotel, Sydney, Australia
July 11-15, 2010
Law Faculty, Rouen, Normandy, France
June 19-22, 2006
Pittsburgh, Pennsylvania, USA
August 31-September 4, 2002
University of Bristol, Bristol, UK
October 1998
Kitakyushu, Japan
July 3-8, 1994
Budapest, Hungary
June 24-29, 1990
Bordeaux, France
July 9-11, 1986
San Francisco, California, USA
This lecture series commemorates Geoffrey Wingfield Harris, FRS (1913-1971), the ‘father’ of neuroendocrinology.
Harris showed through a series of elegant experiments that ‘the hypothalamo-hypophysial portal vasculature is necessary for the maintenance and control of normal activity of the anterior pituitary’, contrasting this mechanism with the direct neural control of the posterior pituitary. He proposed that ‘of the many possibilities’ to explain these effects ‘the most likely seems to be that nerve fibres from the hypothalamus liberate some humoral substance(s) into the capillaries of the primary plexus in the median eminence and that this substance is carried by the portal vessels to excite or inhibit the cells of the pars distalis’ (Harris GW, 1955; Neural Control of the Pituitary Gland. Monographs of the Physiological Society 3, London: Edward Arnold, 298pp).
The Geoffrey Harris Memorial Lectureship, first awarded in 1974 to Sawyer in New Delhi, was the highest honour of the International Society for Neuroendocrinology (ISN) and continues to be recognized in this manner by the International Neuroendocrine Federation (INF) which succeeded the ISN when it was dissolved in 2000. The honour recognises major contributions by the lecturer to the advancement of knowledge in neuroendocrinology.
The INF Executive Board nominates the Lecturer from up to three names suggested in consultation with the Program and Local Organising Committees of the International Congress of Neuroendocrinology. The INF provides an honorarium for the lecturer.
Lecturers
CH Sawyer (USA) 1974
R Guillemin (USA) 1976
BT Donovan (UK) 1977
B Flerko (Hungary) 1979
SM McCann (USA) 1980
J Meites (USA) 1981
E Knobil (USA) 1982
WW Vale (USA) 1984
KJ Catt (USA) 1985
T Hokfelt (Sweden) 1986
S Nakanishi (Japan) 1988
L Martini (Italy) 1990
B Halasz (Hungary) 1992
D deWied (Netherlands) 1994
M Palkovits (Hungary) 1998
MG Rosenfeld (USA) 2002
RP Millar (Rep S Africa) 2006
IJ Clarke (Australia) 2011
TM Plant (USA) 2014
INF is an academic partnership with the mission of bringing together researchers and promoting relevant discoveries in the field of neuroendocrinology
